Brief Addiction Monitor (BAM) With Scoring & Clinical Guidelines

Similar documents
FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES

Pain relief after surgery

Advantage EAP Employee Assistance Program

COPING WITH STRESS IN PARENTS OF CHILDREN AFTER RENAL TRANSPLANTATION

For our protection, we require verification that you have received this notice. Therefore, please sign below.

Instructions regarding referral of patients to the Persistent Pain Service

For our protection, we require verification that you have received this notice. Therefore, please sign below.

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

Module 6: Goal Setting

BARNSLEY BUSINESS DELIVERY UNIT COMMUNITY SUBSTANCE MISUSE TEAM

Making Medicare + Medi-Cal Work for California s Dual Eligibles

The Dizziness Handicap Inventory ( DHI )

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

Record of Revisions to Patient Tracking Spreadsheet Template

ANXIETY SYMPTOMS INTERVENTION SESSION HANDOUTS. Introduction to Fighting Fear by Facing Fear. Making a Fears and Worries List

HSC 106 Personal Health Plan for Learning Activities & Assessment linked to Michigan Teacher Preparation Standards

Completing the NPA online Patient Safety Incident Report form: 2016

Finding the right 90 people in 90 days and what to do with them:

Post Distribution Monitoring Report

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Initial Postoperative Knee Care Patella or Quadriceps Tendon Repairs: - Videos are available on Dr. Witty s website: drjeffreywitty.

Understanding Your Total-Cholesterol-to-HDL Ratio

17831 Murdock Circle Port Charlotte, FL Information: or

Thank you for committing to engage pharmacists regarding the incredible opportunity for them to prevent opioid overdose deaths by providing naloxone!

GSB of EDA Meeting Minutes

Through our exceptional health care services, we reveal the healing presence of God.

Through our exceptional health care services, we reveal the healing presence of God.

Frontier School of Innovation District Wellness Policy

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program?

NIDA Quick Screen V1.0F1

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information

Collaborative Support Programs of New Jersey Institute for Wellness and Recovery Initiatives

Postoperative Anterior Cruciate Ligament Reconstruction Care WITH meniscus repair:

PILI Ohana Facilitator s Guide

Psychological aspects of breast cancer. Dr Caroline Dancyger & Dr Esther Hansen

Community Health Worker / Certified Recovery Specialist Training Application

British Sign Language (BSL) Plan October 2018 Scottish Charity Regulator

2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizations, Clinical Cascade Breakout Session TB/HIV EXERCISE

Preventing Suicide: Review of Safety Protocol for Suicidal Students. Maureen Cooper Jamie Anderson

NIDA-Modified ASSIST Prescreen V1.0 1

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:

FTD RESEARCH: The Value of Studies and Opportunities for Involvement

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

Career Confidence. by Kevin Gaw

Mental Health Statistics Improvement Plan (MHSIP) Consumer Survey

NIDA-Modified ASSIST - Prescreen V1.0*

Interpretation. Historical enquiry religious diversity

Alcohol & Substance Misuse Policy. St Mary s CE Academy Trading Company. Date: Spring 2017 Date of Next Review: Summer 2018

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.

State Health Improvement Plan Choosing Priorities, Creating a Plan. DHHS DPH - SHIP Priorities (Sept2016) 1

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS

2019 Canada Winter Games Team NT Female Hockey Selection Camp August 16-19, 2018

EDPS 475: Instructional Objectives for Midterm Exam Behaviorism

New Patient Information Sheet PLEASE COMPLETE THIS ENTIRE FORM. Date of Appointment: / /

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)

Session78-P.doc College Adjustment And Sense Of Belonging Of First-Year Students: A Comparison Of Learning Community And Traditional Students

NEW PATIENT QUESTIONNAIRE-ADULT

2017 Optum, Inc. All rights reserved BH1124_112017

Self-Awareness Exercise:

Ontario Dress Purple Day: Lesson 3

Climate Change and The 12 Step Framework

What is Measurement Based Care?

You may have a higher risk of bleeding if you take warfarin sodium tablets and:

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

PILI Lifestyle Program Facilitator s Guide

MEDICATION GUIDE. (canagliflozin) Tablets

Understanding your thumb osteoarthritis

PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS

Before Your Visit: Mohs Skin Cancer Surgery

Survey Among the AvMed Physician Network

VOLUME 6: Patient Resources 1

RU Interprofessional: Collaborating for Healthy Communities WOLCOTT CREEK IPE SIMULATION STUDENT WORKSHEET

CHS 283: Evidence-based Health Promotion for Older Adults

Individual Assessments for Couples Treatment with HFCA

Knee Class Fremont Physical Therapy

PET FORM Planning and Evaluation Tracking ( Assessment Period)

Percutaneous Nephrolithotomy (PCNL)

2018 Medical Association Poster Symposium Guidelines

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

Prescribing Safely to Prevent Misuse & Diversion

HOSA 105 EMERGENCY PREPAREDNESS

University of Rochester Course Evaluation Project. Ronald D. Rogge. Associate Professor. Ista Zahn. Doctoral Candidate

Success Criteria: Extend your thinking:

William Paterson University College of Science and Health DEPARTMENT OF PUBLIC HEALTH HealthyU Syllabus

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

EVALUATION OF POVERTY AND STIGMA SESSIONS

Programme of Learning. Physical Education. Key Stage 4 Year 10 BTEC Sport

Frequently Asked Questions: IS RT-Q-PCR Testing

CARE TRANSITIONS COACHES ALZHEIMER S TRAINING FACILITATOR GUIDE

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS

ALCAT FREQUENTLY ASKED QUESTIONS

9200 Calumet Avenue Sincer Jacob, PA-C Munster, IN Jessica Morin, ATC Deanna Cozzi, ATC

2012 Indiana Parent/Family Needs Assessment Survey

I am having a Rotator Cuff Repair

Colonoscopy MoviPrep Split-dose Prep Guide

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

The Mental Capacity Act 2005; a short guide for the carers and relatives of those who may need support. Ian Burgess MCA Lead 13 February 2017

Transcription:

Brief Addictin Mnitr (BAM) With Scring & Clinical Guidelines Participant ID: Interviewer ID (Clinician Initials): Date: Methd f Administratin: Clinician Interview Self Reprt Phne Time Started: : Instructins This is a standard set f questins abut several areas f yur life such as yur health, alchl and drug use, etc. The questins generally ask abut the past 3 days. Please cnsider each questin and answer as accurately as pssible. 1. In the past 3 days, wuld yu say yur physical health has been? Excellent () Very Gd (1) Gd (2) Fair (3) Pr (4) 2. In the past 3 days, hw many nights did yu have truble falling asleep r staying asleep? 3. In the past 3 days, hw many days have yu felt depressed, anxius, angry r very upset thrughut mst f the day? 4. In the past 3 days, hw many days did yu drink ANY alchl? (Skip t #6) ()

. In the past 3 days, hw many days did yu have at least drinks (if yu are a man) r at least 4 drinks (if yu are a wman)? [One drink is cnsidered ne sht f hard liqur (1. z.) r 12- unce can/bttle f beer r unce glass f wine.] 6. In the past 3 days, hw many days did yu use any illegal/street drugs r abuse any prescriptin medicatins? (Skip t #8) () 7. In the past 3 days, hw many days did yu use any f the fllwing drugs: 7A. Marijuana (cannabis, pt, weed)? 16-3 7B. Sedatives/Tranquilizers (e.g., benzs, Valium, Xanax, Ativan, Ambien, barbs, Phenbarbital, dwners, etc.)? 16-3 7C. Ccaine/Crack? 16-3 2

7D. Other Stimulants (e.g., amphetamine, methamphetamine, Dexedrine, Ritalin, Adderall, speed, "crystal meth", ice, etc.)? 16-3 7E. Opiates (e.g., Herin, Mrphine, Dilaudid, Demerl, Oxycntin, xy, cdeine (Tylenl 2,3,4), Perccet, Vicdin, Fentanyl, etc.)? 16-3 7F. Inhalants (glues/adhesives, nail plish remver, paint thinner, etc.)? 16-3 7G. Other drugs (sterids, nn-prescriptin sleep/diet pills, Benadryl, Ephedra, ther verthe-cunter/unknwn medicatins)? 16-3 8. In the past 3 days, hw much were yu bthered by cravings r urges t drink alchl r use drugs? Nt at all () Mderately (2) Cnsiderably (3) 3

9. Hw cnfident are yu in yur ability t be cmpletely abstinent (clean) frm alchl and drugs in the next 3 days? Nt at all () Mderately (2) Cnsiderably (3) 1. In the past 3 days, hw many days did yu attend self-help meetings like AA r NA t supprt yur recvery? 11. In the past 3 days, hw many days were yu in any situatins r with any peple that might put yu at an increased risk fr using alchl r drugs (i.e., arund risky peple, places r things )? 12. Des yur religin r spirituality help supprt yur recvery? Nt at all () Mderately (2) Cnsiderably (3) 13. In the past 3 days, hw many days did yu spend much f the time at wrk, schl, r ding vlunteer wrk? 4

14. D yu have enugh incme (frm legal surces) t pay fr necessities such as husing, transprtatin, fd and clthing fr yurself and yur dependents? N () Yes (4) 1. In the past 3 days, hw much have yu been bthered by arguments r prblems getting alng with any family members r friends? Nt at all () Mderately (2) Cnsiderably (3) 16. In the past 3 days, hw many days were yu in cntact r spent time with any family members r friends wh are supprtive f yur recvery? 17. Hw satisfied are yu with yur prgress tward achieving yur recvery gals? Nt at all (4) Slightly (3) Mderately (2) Cnsiderably (1) Extremely () Time Finished: :

Specific items t attend t, and suggested referrals, include: #1 (health), if scred 3 r 4, refer t primary care #3 (md), if scred 2, 3, r 4, prceed t further assessment and address within SUD specialty care r refer t mental health clinic if indicated #,6,7 (heavy alchl use, any drug use, specific drug use), if any scred 1 r higher, discuss with patient and cnsider adjusting treatment (e.g., higher level f care r changing mdality) #8 (craving), if scred 3 r 4, cnsider medicatin such as Naltrexne #14 (adequate incme), if scred, refer t case management #16 (scial supprt), if scred, 1, r 2 cnsider adding netwrk supprt #17 (satisfactin with prgress), if scred 3 r 4, discuss mdifying r supplementing treatment Nte: Examining scres frm individual items as described abve is the mst clinically relevant use f this measure. Summary scres are mre useful fr aggregating acrss patients. Aggregate scring, r subscale scring, is supplementary and very preliminary, based n clinical judgment rather than empirical data. Preliminary Subscale Scring infrmatin Sum f Items 4,, & 6 = Use (Scres range frm t 12 with higher scres meaning mre Use) Sum f Items 1, 2, 3, 8, 11, & 1 = Risk factrs (Scres range frm t 24 with higher scres meaning mre Risk) Sum f Items 9, 1, 12, 13, 14, & 16 = Prtective factrs (Scres range frm t 24 with higher scres meaning mre Prtectin) Number in ( ) is pints fr each respnse *Item 7 (7A-7G) are nt scred as part f the subscales but prvide elabratin fr item 6. *Item 17 can be used as an verall assessment f treatment prgress, but is nt scred n any f the specific subscales. Clinical guidelines: The three subscales include: Use: If a patient scres a 1 r greater, it calls fr further examinatin and clinical attentin, e.g. cnsider additin f pharmactherapy r higher level f care, add mtivatinal interviewing. Any alchl use (item #4) Heavy alchl use (item #) Any drug use (item #6) Risk Factrs: If a patient scres a 12 r greater, it calls fr further examinatin and clinical attentin, e.g. refer fr medical r mental health cnsulatin, add CBT r relapse preventin skills training. Cravings (item #8) Physical Health (item #1) Sleep (item #2) Md (item #3) Risky situatins (item #11) Family/scial prblems (item #1) Prtective Factrs: If a patient scres a 12 r belw, it calls fr further examinatin and clinical attentin, e.g. treatment plan might include building sber supprt netwrks, 12 step facilitatin, r wrk with a case manager fr wrk r incme assistance. Self-efficacy (item #9) Self-help behavirs (item #1) Religin/spirituality (item #12) Wrk/schl participatin (item #13) Adequate Incme (item #14) Sber supprt (item #16) 6

Ntes: It is imprtant t cmpare mst recent BAM scres with prir BAM scres t assess changes in functining and risk status. The gal is t see sizeable changes n each scale with each administratin f the BAM. It is imprtant t take int cnsideratin the relative scres n risk and prtective factrs: If prtective factr scre is greater than risk factr scre, the patient is less at risk fr use. 2 1 1 Risk Factrs Prtective Factrs Beneficial Risk/Prtective Rati 1 If risk factr scre is greater than prtective factr scre, the patient is mre at risk fr use. 2 1 1 Risk Factrs Prtective Factrs Harmful Risk/Prtective Factr Rati 1 If risk factr scre is is equal t prtective factr scre, the patient is at risk fr use and a fcus f treatment shuld be t shift the balance t building prtective factrs and cping with risk factrs. 2 1 1 Risk Factrs Prtective Factrs Balanced scres=wrk n shifting 1 7